Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
[Medical therapy for smoking cessation]
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1195956
Author(s) Zeller, Andreas
Author(s) at UniBasel Zeller, Andreas
Year 2010
Title [Medical therapy for smoking cessation]
Journal Therapeutische Umschau
Volume 67
Number 8
Pages / Article-Number 419-25
Abstract Tobacco smoking is the leading cause of preventable morbidity and premature death. Physicians are in the unique position to promote smoking cessation and to support patients in quitting smoking is a key task for every single health care provider. Counselling smoking cessation is clearly shown to be both efficient and cost-effective in terms of years of live saved. Nicotine is highly addictive and to achieve long-term abstinence pharmacotherapy is frequently inevitable. Nicotine replacement therapy is efficacious and doubles the odds of permanently abstain from smoking. Further, strong evidence supports the use of buproprion, an atypical antidepressive agent, for quit smoking. Varenicline is the first medication specifically developed for smoking cessation. Varenicline is a partial agonist and antagonist at the nicotinic receptor that reduces craving, withdrawal symptoms and the reinforcing effect of smoking. This review summarises the current clinical data on the pharmacotherapy for smoking cessation and provides practical advice for daily clinical practice.
Publisher Hans Huber
ISSN/ISBN 0040-5930
edoc-URL http://edoc.unibas.ch/dok/A6006135
Full Text on edoc No
Digital Object Identifier DOI 10.1024/0040-5930/a000074
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/20687045
ISI-Number MEDLINE:20687045
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.585 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
14/05/2024